 LONDON and NEW YORK, Nov. 10, 2020 GLOBE NEWSWIRE -- MeiraGTx Holdings plc Nasdaq: MGTX, a vertically integrated, clinical stage gene therapy company, today announced that Alexandria Forbes, Ph.D., president and chief executive officer, will present at the Barclays Gene Editing Gene Therapy Summit on Monday, November 16, 2020 at 1:30 p.m. ET. 